Xilis

Xilis company information, Employees & Contact Information

Explore related pages

Related company profiles:

Developing next generation technologies for precision medicine and drug discovery.
Looking for a particular Xilis employee's phone or email?

Xilis Questions

News

Xilis nets $70M to build out organoid-generating platform for cancer treatment, drug development - Fierce Biotech

Xilis nets $70M to build out organoid-generating platform for cancer treatment, drug development Fierce Biotech

Collaboration to advance technology and cancer therapies from MD Anderson and Xilis - MD Anderson Cancer Center

Collaboration to advance technology and cancer therapies from MD Anderson and Xilis MD Anderson Cancer Center

Xilis: Micro-tumor production grows hope in the fight against cancer - Silicon Valley Bank

Xilis: Micro-tumor production grows hope in the fight against cancer Silicon Valley Bank

Xilis’ Precision Oncology Platform Guides Treatment and Drug Discovery - Genetic Engineering and Biotechnology News

Xilis’ Precision Oncology Platform Guides Treatment and Drug Discovery Genetic Engineering and Biotechnology News

Xilis Announces Series A Extension, Bringing Total Round to Over US$89 Million - Business Wire

Xilis Announces Series A Extension, Bringing Total Round to Over US$89 Million Business Wire

Biotech startup using AI to take guesswork out of cancer drug selection raises $70M - MedCity News

Biotech startup using AI to take guesswork out of cancer drug selection raises $70M MedCity News

Texas organization grants $68.5M to Houston institutions for recruitment, research - InnovationMap

Texas organization grants $68.5M to Houston institutions for recruitment, research InnovationMap

Micro-organosphere model may help advance precision oncology - National Cancer Institute (.gov)

Micro-organosphere model may help advance precision oncology National Cancer Institute (.gov)

A Mubadala-backed biotech is using patient tumor tissue grown in a petri dish to change precision oncology - Endpoints News

A Mubadala-backed biotech is using patient tumor tissue grown in a petri dish to change precision oncology Endpoints News

Durham biotech firm Xilis, bolstered with $89M, forms advisory board - WRAL Techwire

Durham biotech firm Xilis, bolstered with $89M, forms advisory board WRAL Techwire

Using Patient-Derived Organoids to Develop Novel Therapies for Complex and Inherited Diseases - Genetic Engineering and Biotechnology News

Using Patient-Derived Organoids to Develop Novel Therapies for Complex and Inherited Diseases Genetic Engineering and Biotechnology News

Top Xilis Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant